AssetMark Inc’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

AssetMark Inc’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.01K	Sell	169 -87	-34%	-$2.49K	﹤0.01%	2772
2026 Q2	$7.68K	Buy	256 +231	+924%	+$6.56K	﹤0.01%	2548
2026 Q1	$750	Buy	25 +3	+14%	+$99	﹤0.01%	3096
2025 Q4	$719	Sell	22 -20	-48%	-$646	﹤0.01%	3021
2025 Q3	$1.46K	Buy	42 +30	+250%	+$960	﹤0.01%	2701
2025 Q2	$336	Buy	+12	New	+$322	﹤0.01%	2804
2021 Q4	–	Sell	-171	Closed	-$9K	–	1561
2021 Q3	$9K	Hold	171	–	–	﹤0.01%	1064
2021 Q2	$12K	Sell	171 -641	-79%	-$48.9K	﹤0.01%	964
2021 Q1	$63K	Sell	812 -2,539	-76%	-$234K	﹤0.01%	695
2020 Q4	$332K	Sell	3,351 -3,447	-51%	-$422K	﹤0.01%	492
2020 Q3	$965K	Buy	6,798 +902	+15%	+$150K	0.01%	337
2020 Q2	$1.16M	Buy	5,896 +453	+8%	+$93.8K	0.01%	317
2020 Q1	$1.07M	Buy	5,443 +5,335	+4,940%	+$1.15M	0.01%	312
2019 Q4	$22K	Sell	108 -14	-11%	-$2.59K	﹤0.01%	911
2019 Q3	$19K	Buy	+122	New	+$20K	﹤0.01%	888

Other funds holding LKFT

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

AssetMark Inc's LKFT Position: Q3 2026 in Review

AssetMark Inc reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 34% in Q3 2026, selling an estimated $2.49K and leaving 169 shares worth $5.01K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

AssetMark Inc first reported a position in LKFT in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.16M in Q2 2020. 8 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

AssetMark Inc held 169 shares of Lakefront Biotherapeutics American Depositary Shares worth $5.01K as of Q3 2026.
AssetMark Inc sold 87 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $2.49K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2772 holding.
AssetMark Inc first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 15 quarters since.
AssetMark Inc's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.16M in Q2 2020.
8 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.